The case surrounding Wockhardt’s’ codeine creation practices has ignited a major controversy. Allegations surfaced suggesting likely data manipulation and deficient oversight during the medication's fabrication. This led to regulatory investigation from the United States FDA, culminating in import restrictions and sparking grave questions about